40.46
price up icon3.61%   1.41
pre-market  Pre-market:  41.00   0.54   +1.33%
loading
Harmony Biosciences Holdings Inc stock is traded at $40.46, with a volume of 840.35K. It is up +3.61% in the last 24 hours and up +18.03% over the past month. Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
See More
Previous Close:
$39.05
Open:
$40
24h Volume:
840.35K
Relative Volume:
1.19
Market Cap:
$2.31B
Revenue:
$681.88M
Net Income/Loss:
$122.63M
P/E Ratio:
19.18
EPS:
2.11
Net Cash Flow:
$220.18M
1W Performance:
+11.09%
1M Performance:
+18.03%
6M Performance:
+26.28%
1Y Performance:
+27.80%
1-Day Range:
Value
$39.65
$40.93
1-Week Range:
Value
$35.72
$40.93
52-Week Range:
Value
$28.14
$41.61

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Name
Name
Harmony Biosciences Holdings Inc
Name
Phone
(484) 539-9800
Name
Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Name
Employee
246
Name
Twitter
Name
Next Earnings Date
2024-10-29
Name
Latest SEC Filings
Name
HRMY's Discussions on Twitter

Compare HRMY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
HRMY
Harmony Biosciences Holdings Inc
40.46 2.31B 681.88M 122.63M 220.18M 2.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-17-24 Initiated H.C. Wainwright Buy
Oct-10-24 Resumed Raymond James Outperform
Sep-10-24 Initiated UBS Buy
Jun-21-24 Initiated Citigroup Buy
Jan-02-24 Downgrade BofA Securities Neutral → Underperform
Sep-25-23 Downgrade Goldman Neutral → Sell
Sep-07-23 Initiated Berenberg Buy
Apr-20-23 Initiated BofA Securities Neutral
Oct-14-22 Upgrade Janney Neutral → Buy
Oct-14-22 Upgrade Jefferies Hold → Buy
Aug-03-22 Downgrade Jefferies Buy → Hold
Jul-13-22 Downgrade Goldman Buy → Neutral
Jul-07-22 Initiated Mizuho Buy
Apr-14-22 Initiated Cantor Fitzgerald Overweight
Dec-01-21 Initiated Oppenheimer Outperform
Nov-04-21 Initiated Raymond James Outperform
Sep-23-21 Initiated Needham Buy
Mar-29-21 Upgrade Goldman Neutral → Buy
Sep-14-20 Initiated Goldman Neutral
Sep-14-20 Initiated Jefferies Buy
Sep-14-20 Initiated Piper Sandler Overweight
View All

Harmony Biosciences Holdings Inc Stock (HRMY) Latest News

pulisher
Jan 21, 2025

Harmony Biosciences chief commercial officer sells shares worth $1.15m By Investing.com - Investing.com Canada

Jan 21, 2025
pulisher
Jan 21, 2025

ARS Investment Partners LLC Invests $841,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Jan 21, 2025
pulisher
Jan 20, 2025

Should Value Investors Buy Harmony Biosciences (HRMY) Stock? - Yahoo Finance

Jan 20, 2025
pulisher
Jan 20, 2025

Harmony Biosciences stock reaffirms buy rating ahead of Q4 results - MSN

Jan 20, 2025
pulisher
Jan 20, 2025

What is HC Wainwright's Forecast for HRMY FY2029 Earnings? - MarketBeat

Jan 20, 2025
pulisher
Jan 17, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 10,507 Shares - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

HC Wainwright Reiterates "Buy" Rating for Harmony Biosciences (NASDAQ:HRMY) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Harmony Biosciences stock reaffirms buy rating ahead of Q4 results By Investing.com - Investing.com Australia

Jan 17, 2025
pulisher
Jan 17, 2025

H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com

Jan 17, 2025
pulisher
Jan 17, 2025

Hennion & Walsh Asset Management Inc. Raises Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Harmony Biosciences officer sells shares worth $388,840 By Investing.com - Investing.com Canada

Jan 16, 2025
pulisher
Jan 16, 2025

Harmony Biosciences officer sells shares worth $388,840 - Investing.com

Jan 16, 2025
pulisher
Jan 16, 2025

A Glimpse Into The Expert Outlook On Harmony Biosciences Through 7 Analysts - Benzinga

Jan 16, 2025
pulisher
Jan 15, 2025

Harmony Biosciences chief commercial officer sells shares worth $265,946 By Investing.com - Investing.com South Africa

Jan 15, 2025
pulisher
Jan 15, 2025

(HRMY) Trading Advice - Stock Traders Daily

Jan 15, 2025
pulisher
Jan 15, 2025

Harmony Biosciences chief commercial officer sells shares worth $265,946 - Investing.com

Jan 15, 2025
pulisher
Jan 15, 2025

How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48% - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Harmony Biosciences price target raised to $32 from $31 at BofA - Yahoo Finance

Jan 15, 2025
pulisher
Jan 14, 2025

HRMY or RGEN: Which Is the Better Value Stock Right Now? - Yahoo Finance

Jan 14, 2025
pulisher
Jan 14, 2025

JPMorgan Chase & Co. Purchases 93,622 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Harmony stock remains Outperform at Oppenheimer, guidance supports optimism By Investing.com - Investing.com Australia

Jan 13, 2025
pulisher
Jan 13, 2025

Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential - Yahoo Finance

Jan 13, 2025
pulisher
Jan 13, 2025

Harmony Biosciences (NASDAQ:HRMY) Shares Gap UpHere's What Happened - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Harmony Biosciences' (HRMY) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $61 at Oppenheimer - StreetInsider.com

Jan 13, 2025
pulisher
Jan 13, 2025

Harmony Biosciences reports strong revenue growth for WAKIX By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 13, 2025

Harmony Biosciences reports strong revenue growth for WAKIX - Investing.com India

Jan 13, 2025
pulisher
Jan 13, 2025

Harmony Biosciences Projects Strong Revenue Growth for 2025 - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Harmony Biosciences (HRMY) Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts - StreetInsider.com

Jan 13, 2025
pulisher
Jan 13, 2025

Harmony Biosciences Revenue Surges 23% to $714M, Sets Ambitious $820M Target for 2025 - StockTitan

Jan 13, 2025
pulisher
Jan 12, 2025

Top 10 Small Cap Stocks to Buy with the Highest Upside Potential - Insider Monkey

Jan 12, 2025
pulisher
Jan 07, 2025

Top 5 US Stocks To Buy In January 2025 - Investing.com

Jan 07, 2025
pulisher
Jan 04, 2025

HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCE - GuruFocus.com

Jan 04, 2025
pulisher
Jan 02, 2025

Principal Financial Group Inc. Cuts Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Jan 02, 2025
pulisher
Dec 28, 2024

Brokerages Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $49.80 - MarketBeat

Dec 28, 2024
pulisher
Dec 26, 2024

HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT - Kilgore News Herald

Dec 26, 2024
pulisher
Dec 25, 2024

How the (HRMY) price action is used to our Advantage - Stock Traders Daily

Dec 25, 2024
pulisher
Dec 24, 2024

Harmony Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference - MSN

Dec 24, 2024
pulisher
Dec 24, 2024

Harmony Biosciences (NASDAQ:HRMY) Trading Down 2.3%What's Next? - MarketBeat

Dec 24, 2024
pulisher
Dec 24, 2024

Declining Stock and Solid Fundamentals: Is The Market Wrong About Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)? - Simply Wall St

Dec 24, 2024
pulisher
Dec 20, 2024

Research Analysts Offer Predictions for HRMY FY2024 Earnings - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

State Street Corp Has $49.62 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.

Dec 19, 2024
pulisher
Dec 19, 2024

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - BioSpace

Dec 19, 2024
pulisher
Dec 17, 2024

HC Wainwright & Co. Initiates Coverage of Harmony Biosciences Holdings (HRMY) with Buy Recommendation - MSN

Dec 17, 2024
pulisher
Dec 17, 2024

Harmony Biosciences (NASDAQ:HRMY) Shares Up 3.6%Here's Why - MarketBeat

Dec 17, 2024
pulisher
Dec 17, 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Large Decrease in Short Interest - MarketBeat

Dec 17, 2024
pulisher
Dec 17, 2024

Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat

Dec 17, 2024

Harmony Biosciences Holdings Inc Stock (HRMY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Cap:     |  Volume (24h):